Groowe Groowe / Newsroom / MRK
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

MRK News

Merck & Co., Inc.

$1,276.52 Bn Public Safety and Security Global Market Research, Opportunities, Competitive Landscape, and Strategies, 2020-2025, 2025-2030F, 2035F

globenewswire.com
ACN BA CSCO MSI MRK AU IBM

TetraScience ernennt Matt Studney zum Chief Customer Officer und signalisiert damit einen Wandel in der Branche hin zu plattformbasierter wissenschaftlicher KI USA - Deutsch USA - English USA - Français USA - English USA - Nederlands

prnewswire.com
MRK NVDA SNOW GOOG MSFT

TetraScience Appoints Matt Studney as Chief Customer Officer, Signaling Industry Shift Toward Platform-Based Scientific AI USA - English USA - English USA - Deutsch USA - Français USA - Nederlands

prnewswire.com
MRK NVDA GOOG MSFT

JPM Highlights | WuXi Biologics CEO Dr. Chris Chen: Scaled CRDMO Platform Delivering Sustainable High Growth

prnewswire.com
MRK GSK

House Dust Mite Disease Market to Exhibit Substantial Growth at a CAGR of 3.5% During the Forecast Period (2025-2034) | DelveInsight USA - English USA - English

prnewswire.com
ALKS STG GSK SNY TEVA AZN INCY REGN PFE BMY LLY AMGN ABBV GILD BIIB CSL VRTX BHC NVS MRK LEO ALLT CNTB INM

Hazeltree 2025 Year-in-Review Finds Hedge Fund Crowding Diverged Sharply by Region

businesswire.com
GOOGL MSFT META IBM SNPS BAC USB WFC JPM KEY MRK AMGN TMO

Living Security Launches Livvy, the AI-Native Intelligence Powering Predictive Human Risk Management

accessnewswire.com
MA MRK ABT

TetraScience Appoints Matt Studney as Chief Customer Officer, Signaling Industry Shift Toward Platform-Based Scientific AI

prnewswire.com
MRK NVDA DDOG SNOW GOOG MSFT

Systemic Lupus Erythematosus Market to Exhibit Growth at a CAGR of 9.4% During the Forecast Period (2025–2034) Owing to Rising Use of Biologics – Approvals of BENLYSTA and SAPHNELO, Plus a Strong Pipeline | DelveInsight

globenewswire.com
JNJ BIIB NVS VTRS RPRX ABBV AZN MRK RIGL GSK REGN GILD AMGN LLY BMY XBI IBB

Adimab Records Another Year of Double-Digit Clinical Program Growth

prnewswire.com
GSK BIIB NVS BMY REGN VRTX LLY MRK ALNY IVVD ALE SCHR